Amble Health vs IVIM Health vs Mochi Health (2026)
On tirzepatide, the order is IVIM Health↗ ($278) → Mochi Health↗ ($278) → Amble Health ($300) — gaps of $0 and then $22 a month, a $264 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
The three records, one screen
IVIM Health: the record, condensed
IVIM Health’s tirzepatide program bills $278 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Pricing steps with the dose here: from $208 at entry to $278 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $840 a year, which is why every ranking on this site uses the larger number.
A required $75/month membership is part of the deal, and part of the figure above: $203 of medication plus $75 of platform equals the $278 that leaves your account. Judge the membership by what it includes, but compare on the total.
Context for that figure: it ranks #3 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife↗, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.
On semaglutide, the number that matters at IVIM Health is $149 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.
A required $75/month membership is part of the deal, and part of the figure above: $74 of medication plus $75 of platform equals the $149 that leaves your account. Judge the membership by what it includes, but compare on the total.
To place the number: #3 of 20 verified programs, with the floor $16/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $200 a month. A year at this figure: $1,788 monthly-billed.
Operationally at IVIM Health: shipping included; commitment membership mandatory for duration; cancellation membership mandatory; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the IVIM Health page · visit IVIM Health ↗
Mochi Health: the record, condensed
Start with the load-bearing figure: $278 a month, all-in, is what Mochi Health charges for tirzepatide at the 10 mg basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Mochi Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $199 would be exactly that kind of mirage.
To place the number: #4 of 17 verified programs, with the floor $63/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.
Start with the load-bearing figure: $178 a month, all-in, is what Mochi Health charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
Inside that $178 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $99, and it is not a price anyone can actually pay, because the membership cannot be declined.
Context for that figure: it ranks #8 of 20 in the verified semaglutide index — $45/month above the floor (Oak Longevity, $133) — and sits $171 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,136.
Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗
Amble Health: the record, condensed
On tirzepatide, the number that matters at Amble Health is $300 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Amble Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
Context for that figure: it ranks #9 of 17 in the verified tirzepatide index — $85/month above the floor (NexLife, $215) — and sits $149 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,600.
Operationally at Amble Health: shipping unknown; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Amble Health page
Prices, gaps, and what sits inside them
IVIM Health holds the low ground at $278 (its $75 membership already inside). Mochi Health follows at $278 (+$0/mo, $0/yr), membership included. Amble Health tops the trio at $300 (+$22/mo over the leader, $264/yr) — note its record’s watch-out below.
The semaglutide picture reshuffles nothing: IVIM Health $149 → Mochi Health $178 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.
Who wins what
Cheapest month-to-month: IVIM Health ($278); cheapest 12-month path: IVIM Health ($3,336); simplest billing (no membership): Amble Health; dose-flat structure: Mochi Health and Amble Health; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: IVIM Health ($149).
Every winner above is a computation, not a placement; the pairwise pages carry the full duels: IVIM Health vs Mochi Health · IVIM Health vs Amble Health (record · record) · Mochi Health vs Amble Health (record · record).
Everything besides the three prices
Memberships: IVIM Health $75/mo (inside its figure); Mochi Health $79/mo (inside its figure); Amble Health none. Structures: IVIM Health step/tiered; Mochi Health dose-flat; Amble Health dose-flat. Pharmacies: IVIM Health not named; Mochi Health named (company-owned compounding facility); Amble Health not named. States: IVIM Health — not published; Mochi Health — most states; Amble Health — not published. Exit terms: IVIM Health — membership mandatory; Mochi Health — cancel membership any time; recurs until cancelled; Amble Health — not published.
The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: IVIM Health source-verified (2026-08-05); Mochi Health source-verified (2026-08-05); Amble Health third-party reported (2026-08-05).
The trio on semaglutide, across time
3 mo: IVIM Health $447 vs Mochi Health $534 6 mo: IVIM Health $894 vs Mochi Health $1,068 12 mo: IVIM Health $1,788 vs Mochi Health $2,136 — monthly-billed totals; prepaid paths where published appear on each provider page.
The trio, annualized
IVIM Health: $3,336/yr monthly-billed; Mochi Health: $3,336/yr monthly-billed; Amble Health: $3,600/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $528 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.
The elimination read
Work it as eliminations rather than a beauty contest. Amble Health enters owing an explanation: $22/month above IVIM Health compounds to $264 a year — real therapy-months of money — so its record has to name what the premium buys (structure the cheaper two lack) or it exits first. Mochi Health survives the first cut only to face the harder question — whether its dose-flat structure removes titration repricing is worth $0 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. IVIM Health is what remains: the arithmetic answer at $278, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.
The same trio on best published rate: IVIM Health $278 → Mochi Health $278 → Amble Health $300 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — IVIM Health $834, Mochi Health $834, Amble Health $900; 6 months — IVIM Health $1,668, Mochi Health $1,668, Amble Health $1,800. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.
Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): IVIM Health 4/5 · Mochi Health 5/5 · Amble Health 3/5. The gap between Mochi Health (5/5) and Amble Health (3/5) is itself information: undisclosed axes are where the questions in each provider’s review earn their keep. The concrete splits — pharmacy named: Mochi Health yes, IVIM Health and Amble Health no — convert directly into pre-purchase emails. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.
The three-way verdict compresses cleanly: IVIM Health is the default on arithmetic; Mochi Health earns the middle only where its structure (membership services) solves something the floor does not; and Amble Health’s $22/month premium over the leader — $264 a year, roughly 0.9 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.
Frequently asked
Which is cheapest: Amble Health, IVIM Health, or Mochi Health?
IVIM Health, at $278/month all-in tirzepatide — $0 under Mochi Health and $22 under Amble Health; on semaglutide the cheapest of the three is IVIM Health at $149. Captured 2026-08-09.
Which of the three is best over a full year?
IVIM Health’s best path prices twelve months at $3,336; monthly-billed years run IVIM Health $3,336, Mochi Health $3,336, Amble Health $3,600.
Are these rankings paid or editorial?
Neither — they are sorts of the public dataset on the all-in maintenance basis, regenerated on every data change; the methodology page defines the basis and the JSON lets you recompute every figure here.